eLife (Jan 2022)

Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination

  • George Elias,
  • Pieter Meysman,
  • Esther Bartholomeus,
  • Nicolas De Neuter,
  • Nina Keersmaekers,
  • Arvid Suls,
  • Hilde Jansens,
  • Aisha Souquette,
  • Hans De Reu,
  • Marie-Paule Emonds,
  • Evelien Smits,
  • Eva Lion,
  • Paul G Thomas,
  • Geert Mortier,
  • Pierre Van Damme,
  • Philippe Beutels,
  • Kris Laukens,
  • Viggo Van Tendeloo,
  • Benson Ogunjimi

DOI
https://doi.org/10.7554/eLife.68388
Journal volume & issue
Vol. 11

Abstract

Read online

Antigen recognition through the T cell receptor (TCR) αβ heterodimer is one of the primary determinants of the adaptive immune response. Vaccines activate naïve T cells with high specificity to expand and differentiate into memory T cells. However, antigen-specific memory CD4 T cells exist in unexposed antigen-naïve hosts. In this study, we use high-throughput sequencing of memory CD4 TCRβ repertoire and machine learning to show that individuals with preexisting vaccine-reactive memory CD4 T cell clonotypes elicited earlier and higher antibody titers and mounted a more robust CD4 T cell response to hepatitis B vaccine. In addition, integration of TCRβ sequence patterns into a hepatitis B epitope-specific annotation model can predict which individuals will have an early and more vigorous vaccine-elicited immunity. Thus, the presence of preexisting memory T cell clonotypes has a significant impact on immunity and can be used to predict immune responses to vaccination.

Keywords